Telix is in a strong financial position with net cash of AUD 140 million as of December 2024. We forecast free cash flow averaging 87% of net income over the next 10 years, and in the absence of major ...
Chimerix holds the potential to have the first approval of dordaviprone for treating recurrent H3 K27M mutant high-grade ...
We recently compiled a list of the 9 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a look at where iCAD, Inc. (NASDAQ:ICAD) stands against the other AI stocks.
In this review, GlobalData considers the products both approved and priced in 2024 and the factors that influenced their ...
The RetinalGeniXâ„¢ imaging system is designed to allow routine screenings to be conducted by general practitioners, optometric ...
IntroductionOxidative stress, caused by an imbalance between reactive oxygen species (ROS) and antioxidant defenses, plays a central role in the ...
Pope Francis was admitted to Rome’s Gemelli Hospital on Friday, Feb. 14, to undergo testing and treatment for bronchitis, the ...
RetinalGenix Technologies Inc OTCQB:RTGN ("RetinalGenix" or the "Company"), announced today that it has achieved an important milestone in developing ...
Krystal Biotech KRYS reported fourth-quarter earnings per share of $1.52, which beat the Zacks Consensus Estimate of $1.29 as ...
"There is lots of different research that goes in within the lab," Limbers said. "It all sort of ties back to trying to ...
A total of 118 recommendations based on expert consensus were published regarding the treatment of hidradenitis suppurativa ...